The EMT phenotype of CTCs in NSCLC patients is also related to other molecular characteristics, such as epidermal growth factor receptor (EGFR) mutation status, which could lead to a new strategy for targeted therapy [6,17]. Here, EGFR is linked to non-small cell lung carcinoma.